Evidence map›Paper›PMID 29023242›Full record

ArticleEpidemiology (Cambridge, Mass.)2018

The Authors Respond.

Catherine R Lesko, Ashley L Buchanan, Daniel Westreich, Jessie K Edwards, Michael G Hudgens, Stephen R Cole

Abstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Epidemiology (Cambridge, Mass.), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Catherine R LeskoDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, clesko2@jhu.edu Department of Pharmacy Practice, College of Pharmacy, University of Rhode Island, Kingston, RI Department of Epidemiology, University of North Carolina, Chapel Hill, NC Department of Biostatistics, University of North Carolina, Chapel Hill, NC Department of Epidemiology, University of North Carolina, Chapel Hill, NC.
Ashley L Buchanan
Daniel Westreich
Jessie K Edwards
Michael G Hudgens
Stephen R Cole

Funding

Unsolicited R24 for the CFAR-Network of Integrated Clinical Sciences, CNICSR24AI067039 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Michael S. Saag · 2006 to 2026
$99.4M
Virology, Immunology, and Microbiology CoreP30AI050410 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DAVID M. MARGOLIS · 2001 to 2026
$76.9M
University of North Carolina Womens Interagency HIV Study UNC WIHSU01AI103390 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI ADIMORA, ADAORA A · 2013 to 2018
$11.0M
Lung and HIV Analytical Data Coordinating Center (LHAD-CC)U01HL121812 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI LAU, BRYAN · 2013 to 2017
$3.4M
From patients to policy: innovative epidemiology for implementation scienceDP2HD084070 · NICHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI WESTREICH, DANIEL J · 2014 to 2014
$2.3M
Structural models for treatment and exposure effects in clinical HIV cohortsR01AI100654 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI COLE, STEPHEN R · 2013 to 2016
$1.6M
NHLBI NIH HHS U01 HL121812NIAID NIH HHS P30 AI050410NIAID NIH HHS R01 AI100654NIAID NIH HHS R24 AI067039NIAID NIH HHS U01 AI103390NICHD NIH HHS DP2 HD084070
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID29023242
PMCPMC7314580

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.